Project Grant 2112092
Award Date
5/1/21
Completion Date
4/30/22
Dollars Obligated
$256K
Federal Agency
Division of Industrial Innovation
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
East Case, MD 21202, USA
Similar Awards
This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program provides $305,000.00 in funding to Innotech Precision Medicine, Inc. to develop a microfluidic device for multi-omics diagnosis of cancer. The project aims to create a portable, saliva-based diagnostic system that can rapidly detect cancer biomarkers for early diagnosis, particularly for head and neck cancers. The research will focus on integrating multiple...
This $255,706 National Science Foundation SBIR Phase I Project Grant to Metfora LLC supports the development of a novel multiplexed metabolite diagnostic blood test for early detection of chronic diseases. The NSF Technology, Innovation, and Partnerships program aims to advance science and engineering solutions to national challenges through innovation and partnerships. Specifically, Metfora will use mass spectrometry and artificial intelligence to analyze specific panels of circulating...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,362 to RT Microdx Inc. focuses on developing a novel molecular diagnostic platform for detecting respiratory diseases like strep throat. The platform aims to provide laboratory-quality accuracy for use by non-healthcare professionals in non-clinical settings, enabling rapid and reliable pathogen detection at home. Key technical objectives include optimizing the platform's...
The federal Project Grant award R44HL178137 of $1,213,182.00 was provided by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), under the Cardiovascular Diseases Research program (CFDA 93.837). The grant supports the development of a next-generation, high-flow-rate, low-weight portable oxygen concentrator (POC) by Pranions, Inc. to address the limitations of existing commercial POC options and improve the quality of life for the 1.5 million...
The National Science Foundation (NSF) awarded a $1,213,619 Cooperative Agreement under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Encapsulate Inc., a small disadvantaged business in Farmington, CT. This Phase II Small Business Innovation Research (SBIR) project aims to develop a precision oncology platform that integrates microfluidics, biochips, bioreactors, and 3D tumor models to predict patient-specific cancer drug responses. The proposed technology utilizes...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Cerflux Inc. aims to develop a personalized cancer treatment screening platform. The project will establish guidelines for handling solid tumor biopsy samples, generate 3D bioprinted tumor models for validation, and demonstrate the platform's ability to match patients with the most effective cancer treatments before treatment begins. This innovative approach has the...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Innovation Research (SBIR) project grant, awarded to Anvil Diagnostics Inc. in the amount of $298,646, aims to develop a rapid diagnostic test for sepsis-causing pathogens in plasma samples using digital PCR hardware. The proposed technology seeks to comprehensively identify and quantify a panel of 17 common sepsis-causing pathogens within 4 hours from small blood volumes,...
The National Science Foundation (NSF) awarded a $304,966 Small Business Innovation Research (SBIR) Phase I grant to Kompass Diagnostics Inc., a small business located in Chicago, IL. The objective of this 6-month project is to develop a portable, cost-effective, and rapid point-of-care diagnostic device that uses high-sensitivity biosensors to detect multiple blood-based biomarkers, starting with reproductive hormones. The project aims to address capacity constraints in reproductive care, reduce...
This $305,000 Project Grant was awarded on June 1, 2025 by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program. The purpose of the grant is to develop a cloud-based software platform that can identify multi-omics biomarkers critical for guiding non-small cell lung cancer treatment decisions. The software solution will feature a data portal providing access to validated biomarkers for predicting tumor recurrence/metastasis and drug...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,990 to Scorpido Photonics aims to develop a prototype endoscope-based diagnostic system for rapid, non-invasive detection of microscopic tumors. The project integrates plasmonic nanobubble sensors into a medical device platform and standard endoscope to enable instant, optical detection of cancerous tissues during lung cancer diagnostic procedures. The key product is a...